Open AccessNeurocognitive predictors of treatment outcomes in psychotherapy for comorbid PTSD and substance use disorders.
Author(s) -
J. Cobb Scott,
Kevin G. Lynch,
David P. Cenkner,
Shan M. KehleForbes,
Melissa A. Polusny,
Ruben C. Gur,
Shirley Chen,
Edna B. Foa,
David W. Oslin
Publication year - 2021
Publication title -
journal of consulting and clinical psychology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.582
H-Index - 240
eISSN - 1939-2117
pISSN - 0022-006X
DOI - 10.1037/ccp0000693
Subject(s) - neurocognitive , psycinfo , psychology , clinical psychology , comorbidity , cognition , substance abuse , working memory , psychiatry , verbal memory , cognitive processing therapy , cognitive therapy , medline , political science , law
Comorbidity between posttraumatic stress disorder (PTSD) and substance use disorders (SUD) is common, and both are associated with cognitive dysfunction. However, few studies examine the impact of cognitive deficits on treatment outcomes. Here, we leverage data from a randomized clinical trial of integrated versus phased psychotherapy for SUD and PTSD to examine the relation of cognitive functioning to treatment response.